Timing of buprenorphine adoption by privately funded substance abuse treatment programs: The role of institutional and resource-based interorganizational linkages

Sarah A. Savage, Amanda J. Abraham, Hannah K. Knudsen, Tanja C. Rothrauff, Paul M. Roman

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Identifying facilitators of more rapid buprenorphine adoption may increase access to this effective treatment for opioid dependence. Using a diffusion of innovations theoretical framework, we examine the extent to which programs' interorganizational institutional and resource-based linkages predict the likelihood of being an earlier adopter, later adopter, or nonadopter of buprenorphine. Data were derived from face-to-face interviews with administrators of 345 privately funded substance abuse treatment programs in 2007-2008. Results of multinomial logistic regression models show that interorganizational and resource linkages were associated with timing of adoption. Programs reporting membership in provider associations were more likely to be earlier adopters of buprenorphine. Programs that relied more on resource linkages, such as detailing activities by pharmaceutical companies and the National Institute on Drug Abuse website, were more likely to be earlier adopters of buprenorphine. These findings suggest that institutional and resource-based interorganizational linkages may expose programs to effective treatments, thereby facilitating more rapid and sustained adoption of innovative treatment techniques.

Original languageEnglish
Pages (from-to)16-24
Number of pages9
JournalJournal of Substance Abuse Treatment
Volume42
Issue number1
DOIs
StatePublished - Jan 2012

Bibliographical note

Funding Information:
Data collection for these analyses was funded by research Grant R01DA013110 from the NIDA , and additional support was received from research Grant R01AA015974 from the National Institute on Alcohol Abuse and Alcoholism and research Grant R01DA14482 from NIDA . The opinions expressed are those of the authors and do not reflect the official position of the funding agencies.

Keywords

  • Adoption
  • Buprenorphine
  • Interorganizational linkages

ASJC Scopus subject areas

  • Psychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Timing of buprenorphine adoption by privately funded substance abuse treatment programs: The role of institutional and resource-based interorganizational linkages'. Together they form a unique fingerprint.

Cite this